← All stocks

Prelude Therapeutics Inc

PRLD Net buying

CIK 0001678660 #3089 in the set updated 17 Sep 2026

Bought (120 mo)

$113.56M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$10.40M

$0.00 on a plan · $10.32M straight out of an exercise

Sold at will

$81.27K

1 of 67 sales

Net

+$103.16M

+$113.48M against sales at will

By person

16 insiders · 111 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bonita David P

Director

$41.00M (5)

—

+$41.00M

10,376,317

13.00%

$46.07M

—

ORBIMED ADVISORS LLC entity

Director

$41.00M (5)

—

+$41.00M

10,376,317

13.00%

$46.07M

—

BAKER BROS. ADVISORS LP entity

Director

$30.00M (2)

—

+$30.00M

9,252,951

11.59%

$41.08M

—

Mauro David J

Chief Medical Officer

—

$5.61M (30) scheduled

−$5.61M

0.0000%

$0.00

—

Scherle Peggy

Chief Scientific Officer

—

$2.26M (17) scheduled

−$2.26M

172,920

0.2167%

$767.76K

0.0%

Morosini Deborah

EVP, Chief of Clinical Affairs

$8.44K (1)

$1.00M (6) scheduled

−$995.75K

444

0.0006%

$1.97K

—

Vaddi Krishna

CEO

$873.73K (15)

—

+$873.73K

2,666,981

3.34%

$11.84M

+77.2%

Pierce Christopher

EVP and Chief of Business Oper

$71.25K (1)

$882.45K (6) scheduled

−$811.20K

3,750

0.0047%

$16.65K

—

Piper Brian

Chief Financial Officer

—

$563.36K (7) scheduled

−$563.36K

0.0000%

$0.00

—

Combs Andrew

Chief Chemistry Officer

$268.67K (6)

—

+$268.67K

480,123

0.6016%

$2.13M

+76.5%

Dier Mardi

Director

$190.00K (1)

—

+$190.00K

10,000

0.0125%

$44.40K

—

Chardonnet Laurent

Chief Financial Officer

$117.40K (3)

—

+$117.40K

42,165

0.0528%

$187.21K

+644.3%

Huang Jane

President, CMO

—

$81.27K (1)

−$81.27K

86,917

0.1089%

$385.91K

—

Lim Bryant David

CLO, CFO, Corp Sec.

$35.57K (2)

—

+$35.57K

27,400

0.0343%

$121.66K

—

RA CAPITAL MANAGEMENT, L.P. entity

10% owner

—

6,475,882

8.11%

$28.75M

−17.8%

FRIEDMAN PAUL A

Director

—

500,098

0.6267%

$2.22M

+866.8%

Prelude Therapeutics Inc

By person

Individual transactions

What was left out